125 related articles for article (PubMed ID: 9019362)
21. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
[TBL] [Abstract][Full Text] [Related]
23. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
Chun AW; Cosenza SC; Taft DR; Maniar M
Cancer Chemother Pharmacol; 2009 Dec; 65(1):177-86. PubMed ID: 19466411
[TBL] [Abstract][Full Text] [Related]
25. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy in hepatocellular carcinoma.
Okada S
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
[TBL] [Abstract][Full Text] [Related]
27. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
Eggermont AM
Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
[TBL] [Abstract][Full Text] [Related]
28. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
29. [Harvesting of autologous peripheral blood stem cells following percutaneous isolated hepatic perfusion for patients with advanced hepatocellular carcinoma].
Fujioka Y; Saigo K; Hashimoto M; Kumagai S; Horie O; Takahashi T; Fukumoto T; Ku Y
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1447-51. PubMed ID: 14584276
[TBL] [Abstract][Full Text] [Related]
30. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ
Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721
[TBL] [Abstract][Full Text] [Related]
31. [Troxacitabine].
Gourdeau H; Jolivet J
Bull Cancer; 2004 Mar; 91(3):213-8. PubMed ID: 15171046
[TBL] [Abstract][Full Text] [Related]
32. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system.
Curley SA; Byrd DR; Newman RA; Carrasco CH; Cromeens D; Ellis HJ; Chase J; Dougherty T; Wright K; Bodden W
Anticancer Drugs; 1991 Apr; 2(2):175-83. PubMed ID: 1958862
[TBL] [Abstract][Full Text] [Related]
33. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
34. Surgical approaches to liver metastases.
Alexander HR
Cancer J; 2002; 8 Suppl 1():S68-81. PubMed ID: 12075704
[TBL] [Abstract][Full Text] [Related]
35. Reducing toxicity of cisplatin in cancer chemotherapy by extracorporeal removal of excess cisplatin.
Ambruss CM; Karakousis CP; Stadler A; Stadler I; Ambrus JL; Anthone S; Ambrus JL
J Med; 2002; 33(1-4):119-27. PubMed ID: 12939112
[TBL] [Abstract][Full Text] [Related]
36. Isolated hepatic perfusion: a regional therapy for liver cancer.
Yang ZW; Xu GL
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):12-6. PubMed ID: 14969830
[TBL] [Abstract][Full Text] [Related]
37. Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Boulikas T; Stathopoulos GP; Volakakis N; Vougiouka M
Anticancer Res; 2005; 25(4):3031-9. PubMed ID: 16080562
[TBL] [Abstract][Full Text] [Related]
38. [Hepatic cancer].
Kako M
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):307-10. PubMed ID: 2649003
[TBL] [Abstract][Full Text] [Related]
39. [Preclinical studies for development of anti-cancer drugs: current and historical status and problems].
Okabe M; Kobayashi S; Hirata T; Nakano H; Ikegami J; Inoue K; Komuro T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():302-9. PubMed ID: 7986108
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
Foster BJ; Wiegand RA; LoRusso PM; Baker LH
Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
